Antiviral Combination Approach as a Perspective to Combat Enterovirus Infections

Abzug MJ, Cloud G, Bradley J, Sanchez PJ, Romero J, Powell D, et al. Double blind placebo-controlled trial of pleconaril in inmfants with enterovirus meningitis. Pediatr Infect Dis. 2003; 36: 1523-1532.Search in Google Scholar

Aitken C, Jeffries DJ Nosocomial spread of viral disease. Clinical Microbiology Review. 2001; 14: 528-546.10.1128/CMR.14.3.528-546.2001Search in Google Scholar

Archard LC, Richardson PJ, Olsen EG, Dubowitz V, Sewry C, Bowles NE. The role of coxsackie B viruses in the pathogenesis of myocarditis, dilated cardiomyopathy and inflammatory muscle disease. Biochem Soc Symp. 1987; 53: 51-62.Search in Google Scholar

Aradottir E., Alonso EM, Shulman ST. Severe neonatal enteroviral hepatitis treated with plrconaril. Pediatr Infect Dis. 2001; 20: 457-459.10.1097/00006454-200104000-00022Search in Google Scholar

Chuang JH. (Enterovirus surveillance may be insufficient for estimating burden in Taiwan. Presented at: 14th International Congress on Infectious Diseases, March 9-12th, 2010; Miami, USA. Poster #40.005. 2010.Search in Google Scholar

Diana GD, Rudewicz P., Pevear DC, Nitz TJ, Aldous SC, Robinson DT, et al. Picornavirus inhibitors: Trifluromethyl substitution provides a global protective effect against hepatic metabolism. J Med Chem. 1995; 38: 1355-1371.10.1021/jm00008a014Search in Google Scholar

Galabov AS, Angelova A. Antiviral agents in the prevention and treatment of virus-induced diabetes. Anti-Infective Agents in Medicinal Chemistry. 2006; 5: 293-307.10.2174/187152106777697826Search in Google Scholar

Hayden FG, Herrington DT, Coats TL, Kim K, Cooper EC, Villano SA, et al. Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: Results of 2 double-blind, randomized, placebo- controlled trials. Clin Inf Dis. 2003; 36: 1523-1532.10.1086/375069Search in Google Scholar

Herrmann EC Jr, Herrmann JA. A working hypothesis - virus resistance development as an indicator of specific antiviral activity. Ann NY Acad Sci. 1977; 284: 632-637.10.1111/j.1749-6632.1977.tb21997.xSearch in Google Scholar

Herrmann EC Jr, Herrmann JA, DeLong DC. Prevention of death in mice infected with coxsackievirus A16 using guanidine HCl mixed with substituted benzimidazoles. Antiviral Res. 1982; 2: 339-346.10.1016/0166-3542(82)90003-1Search in Google Scholar

Hyoty H, Taylor KW. The role of viruses in human diabetes. Diabetologia. 2002; 45: 1353-136110.1007/s00125-002-0852-3Search in Google Scholar

Loddo B. Development of drug resistance and dependence in viruses. Pharm Ther. 1980; 10: 431-46010.1016/0163-7258(80)90026-1Search in Google Scholar

Mallia P, Contoli M, Caramori G, Pandit A, Johnston SL, Papi A. Exacerbations of asthma and chronic obstructive pulmonary disease (COPD): focus on virus induced exacerbations. Current pahrmaceutical Design. 2007; 13: 73-97.10.2174/13816120777931377717266589Search in Google Scholar

Melnick JL, Crowther D, Barrera-Oro J. Rapid development of drug-resistant mutants of poliovirus. Science. 1961; 134: 557-557.10.1126/science.134.3478.557Search in Google Scholar

Morens DM, Pallansch MA. Epidemiology. In: Rotbart HA (ed) Human Enterovirus Infections. Washington DC ASM Press. 1995.Search in Google Scholar

Nikolaeva L, Galabov AS. Synergistic inhibitory effect of enviroxime and disoxaril on poliovirus type 1 replication. Acta virol. 1995; 39: 235-241.Search in Google Scholar

Nikolaeva L, Galabov AS. Cytotoxicity of the synergistic antienteroviral combination of enviroxime and disoxaril. Acta virol. 1999a; 43: 263-265.Search in Google Scholar

Nikolaeva L, Galabov AS. In vitro inhibitory effects of dual combinations of picornavirus replication inhibittors. Acta virol. 1999b; 43: 303-311.Search in Google Scholar

Nikolaeva L, Galabov AS. Antiviral effect of the combination of enviroxim and disoxaril on Coxsackievirus B1 infection. Acta virol. 2000; 44: 73-78.Search in Google Scholar

Nikolaeva-Glomb L, Galabov AS. Synergistic drug combinations against the in vitro replication of Coxackie B1 virus. Antiviral Res. 2004; 16: 41-46.Search in Google Scholar

Nikolova I, Galabov AS. Development of resistance to disoxaril in coxsackie B1 virus infected newborn mice. Antivir Res. 2003; 60: 35-40.10.1016/S0166-3542(03)00150-5Search in Google Scholar

Pallansch M, Roos R. Enteroviruses: Polioviruses, coxsackieviruses, echoviruses and newer enteroviruses. In: Knipe DM, Howley PM (ed) Fields Virology, Fifth Edition, Philadelphia, Lippincott Williams & Wilkins. 2006; pp. 895-910.Search in Google Scholar

Pallansch MA. Enterovirus infections, including poliomyelitis. In: Guerrant RL, Walker DH, Weller PF (ed) Tropical Infectious Diseases. Principles, Pathogens and Practice. 3rd edn. 2011.10.1016/B978-0-7020-3935-5.00060-4Search in Google Scholar

Prichard MN, Shipman CJr. A three-dimensional model to analyze drug-drug interactions. Antiviral Res. 1990; 14: 181-206.10.1016/0166-3542(90)90001-NSearch in Google Scholar

Rotbart HA, Webster AD. Treatment of potentially lifethreatening enterovirus infections with plrconaril. Clin Infect Dis. 2001; 32: 228-235.10.1086/318452Search in Google Scholar

Schultheiss HP, Kuhl U. Overview on chronic viral cardiomyopathy/chronic myocarditis. Ernst Schering Res Found Workshop. 2006; 55: 3-18.10.1007/3-540-30822-9_1Search in Google Scholar

Senior K. FDA panel rejects common cold treatment. Lancet Infect Dis. 2002; 2: 264.10.1016/S1473-3099(02)00277-3Search in Google Scholar

Strauss J, Strauss E. Plus-Strand RNA Viruses. In: Viruses and Human Disease. 2008; pp 63-136.10.1016/B978-0-12-373741-0.50006-4Search in Google Scholar

Tan W C. Viruses in asthma exacerbations. Current Opinion in Pulmonary Medicine. 2005; 11: 21-26.Search in Google Scholar

Tauriainen S, Oikarinen S, Oikarinen M, Hyöty H. Enteroviruses in the pathogenesis of type 1 diabetes. Semin Immunopathol. 2011; 33: 45-55.10.1007/s00281-010-0207-y20424841Search in Google Scholar

Turner RB, Dutko FJ, Goldstein NH, Lockwood G, Hayden FG. Efficacy of oral WIN 54954 for prophylaxis of experimental rhinovirus infection. Antimicrob Agents Chemother. 1993; 33: 2069-2074.10.1128/AAC.37.2.2971876568383943Search in Google Scholar

Turner RB, Hendley O. Virucidal hand treatments for prevention of rhinovirus infection. J Antimicrob Chemother. 2005; 56: 805-807.10.1093/jac/dki32916159927Search in Google Scholar

Vassileva-Pencheva R, Galabov AS. Avoiding drug-resistance development by novel approach of combining enteroviral substances against coxsackievirus B1 infection in mice. Antiviral Res. 2010; 85: 366-372.10.1016/j.antiviral.2009.11.00319900482Search in Google Scholar